Inventor · disambiguated record
Peter Michael Huelsmann
Also filed as: HUELSMANN PETER MICHAEL
8 granted patents·12 pending applications·12 citations·filing 2012–2023
79Inventor score
Top patents by PatentIndex Score
20 records- 0183US10730938B2Bispecific antibodies and methods of use in ophthalmologyHOFFMANN LA ROCHE·Filed 2017·Granted Aug 4, 2020·3 cites·13 claims
- 0283US10344085B2Anti-IL-1beta antibodiesHOFFMANN LA ROCHE·Filed 2017·Granted Jul 9, 2019·5 cites·9 claims
- 0379US2024101657A1Antibody that binds to vegf and il-1beta and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0477US10538585B2Anti-ANG2 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Jan 21, 2020·2 cites·6 claims
- 0577US2024270834A1Novel antibody formatHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0675US10087246B2Anti-PDGF-B antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Oct 2, 2018·2 cites·14 claims
- 0773US11866490B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2021·Granted Jan 9, 2024·0 cites·36 claims
- 0871US11130804B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·0 cites·28 claims
- 0971US2023279090A1Non-covalent protein-hyaluronan conjugates for long-acting ocular deliveryGENENTECH INC·Filed 2023·Application pending·0 cites
- 1071US2023256107A1Hyaluronic acid binding derivatives of versican (vg1) for long acting delivery of therapeuticsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1166US2021054083A1Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptidesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1265US10882910B2Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptidesHOFFMANN LA ROCHE·Filed 2018·Granted Jan 5, 2021·0 cites·17 claims
- 1365US2021171619A1Novel antibody formatHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1461US2021024952A1Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptidesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1561US2019218282A1Novel antibody formatHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1660US9963511B2Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptidesHOFFMANN LA ROCHE·Filed 2012·Granted May 8, 2018·0 cites·28 claims
- 1754US2024002538A1Method for the assembly of large nucleic acids from short fragmentsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1852US2016208284A1Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptidesHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 1949US2015232560A1Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereofHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2046US2015038354A1Full length antibody display system for eukaryotic cells and its useHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Michael Huelsmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →